Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284–96.

Article  PubMed  PubMed Central  Google Scholar 

Ford CE, Werner B, Hacker NF, Warton K. The untapped potential of ascites in ovarian cancer research and treatment. Br J Cancer. 2020;123:9–16.

Article  PubMed  PubMed Central  Google Scholar 

Lengyel E. Ovarian Cancer Development and Metastasis. Am J Pathol. 2010;09:177:1053–64.

Article  Google Scholar 

Motohara T, Masuda K, Morotti M, Zheng Y, El-Sahhar S, Chong KY, et al. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene 4/. 2019;38:2885–98.

Article  CAS  Google Scholar 

Uno K, Iyoshi S, Yoshihara M, Kitami K, Mogi K, Fujimoto H et al. Metastatic voyage of Ovarian Cancer cells in Ascites with the assistance of various Cellular Components. Int J Mol Sci. 2022;23.

van Baal JOAM, Van de Vijver KK, Nieuwland R, van Noorden CJF, van Driel WJ, Sturk A, et al. The histophysiology and pathophysiology of the peritoneum. Tissue Cell. 2017;49:95–105.

Article  PubMed  Google Scholar 

Aziz MAAE, Agarwal K, Dasari S, Mitra AAK. Productive cross-talk with the Microenvironment: a critical step in Ovarian Cancer Metastasis. Cancers. 2019;11.

Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer. 2005;5:355–66.

Article  CAS  PubMed  Google Scholar 

Feigenberg T, Clarke B, Virtanen C, Plotkin A, Letarte M, Rosen B, et al. Molecular profiling and clinical outcome of high-grade serous ovarian cancer presenting with low- versus high-volume ascites. Biomed Res Int. 2014;2014:367103.

Article  PubMed  PubMed Central  Google Scholar 

Coosemans AN, Baert T, D’Heygere V, Wouters R, DE Laet L, VAN Hoylandt A, et al. Increased immunosuppression is related to increased amounts of Ascites and Inferior Prognosis in Ovarian Cancer. Anticancer Res. 2019;39:5953–62.

Article  CAS  PubMed  Google Scholar 

Nasioudis D, Byrne M, Ko EM, Haggerty AF, Cory L, Giuntoli RL, Ii, et al. Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2021;31:1579–83.

Article  PubMed  Google Scholar 

Nasioudis D, Byrne M, Ko E, Haggerty A, Cory L, Giuntoli R, et al. Ascites volume at the time of primary debulking and overall survival of patients with advanced-stage epithelial ovarian cancer. Gynecol Oncol. 2021;162:S91.

Article  Google Scholar 

Szender JB, Emmons T, Belliotti S, Dickson D, Khan A, Morrell K, et al. Impact of ascites volume on clinical outcomes in ovarian cancer: a cohort study. Gynecol Oncol. 2017;146:491–7.

Article  PubMed  PubMed Central  Google Scholar 

Quan Q, Zhou S, Liu Y, Yin W, Liao Q, Ren S, et al. Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer. J Obstet Gynaecol Res. 2021;47:1527–35.

Article  CAS  PubMed  Google Scholar 

Janco JMT, Glaser G, Kim B, McGree ME, Weaver AL, Cliby WA, et al. Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2015;138:70–7.

Article  PubMed  Google Scholar 

Lai I, Daniel MN, Rosen BP, May T, Massey C, Feigenberg T. Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer. Int J Gynecol Cancer. 2019. https://doi.org/10.1136/ijgc-2019-000310.

Article  PubMed  Google Scholar 

Chen VW, Ruiz B, Killeen JL, Coté TR, Wu XC, Correa CN. Pathology and classification of ovarian tumors. Cancer. 2003;97(10 Suppl):2631–42.

Article  PubMed  Google Scholar 

Zeppernick F, Meinhold-Heerlein I. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer. Arch Gynecol Obstet. 2014;290:839–42.

Article  CAS  PubMed  Google Scholar 

Tokunaga H, Shimada M, Ishikawa M, Yaegashi N. TNM classification of gynaecological malignant tumours, eighth edition: changes between the seventh and eighth editions. Jpn J Clin Oncol. 2019;49:311–20.

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network, NCCN Clinical Practice Guideline in Oncology; Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, version 3. 2024. Available at: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1453. Retrieved 25 November 2024.

Komiyama S, Katabuchi H, Mikami M, Nagase S, Okamoto A, Ito K, et al. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer. Int J Clin Oncol. 2016;21:435–46.

Article  PubMed  Google Scholar 

Suzuki S, Kajiyama H, Shibata K, Ino K, Nawa A, Sakakibara K, et al. Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? Ann Oncol. 2008;19:1284–7.

Article  CAS  PubMed  Google Scholar 

Rustin GJS, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, et al. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer. 2011;21:419–23.

Article  PubMed  Google Scholar 

Rosenbaum PR, Rubin DB. Reducing Bias in Observational studies using subclassification on the Propensity score. J Am Stat Assoc. 1984;79:516–24.

Article  Google Scholar 

Yoshihara M, Uno K, Tano S, Mayama M, Ukai M, Kondo S, et al. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study. Crit Care. 2015;19:369.

Article  PubMed  PubMed Central  Google Scholar 

Manning-Geist BL, Hicks-Courant K, Gockley AA, Clark RM, Del Carmen MG, Growdon WB et al. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Am J Obstet Gynecol. 2019;221:326.e1-326.e7.

Dabi Y, Huchon C, Ouldamer L, Bendifallah S, Collinet P, Bricou A, et al. Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival. J Transl Med. 2020;18:134.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Mao AS, Seo BR, Zhao X, Gupta SK, Chen M, et al. Compression-induced dedifferentiation of adipocytes promotes tumor progression. Sci Adv. 2020;01:6:eaax5611.

Article  Google Scholar 

Shohei, Iyoshi Masato, Yoshihara Kae, Nakamura Mai, Sugiyama Yoshihiro, Koya Kazuhisa, Kitami Kaname, Uno Kazumasa, Mogi Sho, Tano Hiroyuki, Tomita Keiji, Kajiwara Masayasu, Taki Shigehiro, Yamaguchi Akihiro, Nawa Hiroaki, Kajiyama (2021) Pro‐tumoral behavior of omental adipocyte‐derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer Abstract International Journal of Cancer 149(11) 1961-1972. https://doi.org/10.1002/ijc.v149.11.